Alzheimer's Disease Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged between 55 and 85 years old (inclusive)
• People who have been diagnosed with Alzheimer's disease (AD) according to a specific set of international medical guidelines from 2011
• People with mild-to-moderate Alzheimer's disease, based on a standard memory and thinking test score between 10 and 26
• People who have had relevant blood test results (covering thyroid, vitamins, liver, kidney, blood cells, and other markers) within the past year that are consistent with an Alzheimer's diagnosis, as assessed by the trial doctor
• People who have had a brain CT scan or MRI scan within the past year that is consistent with an Alzheimer's diagnosis, as assessed by the trial doctor
• People already taking Alzheimer's medications (such as memantine or acetylcholinesterase inhibitors) or certain mental health medications (such as anti-anxiety, antidepressant, or antipsychotic drugs), provided the dose has been stable for at least 4 weeks before joining
• People who have a caregiver who is regularly present and able to support them throughout the trial, as assessed by the trial doctor
• People who are enrolled in the French social security system
• People who have provided signed and dated consent to take part, along with their caregiver

Who may not be able to join:

• People who are under a French legal protection measure (such as "sauvegarde de justice", "tutelle", or "curatelle")
• People who are detained or hospitalised without their consent
• Women who have not yet gone through menopause
• People currently taking a disease-modifying Alzheimer's treatment, such as Leqembi®, or any similar treatment that may become authorised in France before the trial ends
• People who live in a medical or care facility
• People who have had surgery on the stomach area or head within the 3 months before joining
• People who have skin sores or wounds on the stomach area or head
• People who have a serious, life-threatening illness (for example, active cancer, unstable heart failure, or severe liver, kidney, or breathing problems)
• People who have had a stroke within the 3 months before joining
• People who have metal objects (such as iron, nickel, cobalt, or metal alloys) on or near the head or stomach, or who have a pacemaker implanted
• People who are at risk of having epileptic seizures
• People who have a genetic form of Alzheimer's disease
• People with significant physical or sensory difficulties that could interfere with neurological testing
• People with chronic psychosis or a history of psychotic episodes
• People with alcohol or drug addiction
• People with known vitamin B12 or folic acid deficiencies that are not being treated with supplements
• People with known hypothyroidism (underactive thyroid) that is not being treated
• People who have taken part in another clinical trial involving an experimental drug or medical device within the 30 days before joining
• People who the trial doctor determines would not be able to attend the required treatment sessions
• People who the trial doctor determines would not be able to complete the required trial assessments

Important: Always verify eligibility with the trial site directly before applying.